Cash flow conversion remains volatile, as demonstrated by the 2025Q4 period where the company generated $10.3 million in free cash flow despite reporting a $19.4 million net loss.
| Metric | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 |
|---|
| Cash from Operations | 27.29M | 23.05M | 14.89M | 8.2M | 34.3M | 19.27M | 18.54M | 19.63M | 19.46M | 9.64M | 11.21M | 5.13M | 1.34M | -1.11M | -1.23M | -1.31M | -2.04M | -418K | -8.43M | -1.66M | -16.26M | -13.07M | -12.69M | -42.18M | -112.44M | -90.75M | -25.7M | -4.9M |
| Operating CF Margin % | 66.94% | 51.23% | 39.43% | 19.77% | 61.07% | 52.48% | 60.29% | - | 51.91% | 43.09% | 47.78% | 29.45% | 20.85% | -175.04% | - | - | -4.52% | -0.64% | -13.87% | -3.07% | -37.71% | -26.73% | -20.8% | -53.33% | -124.11% | -80.3% | -182.27% | -213.04% |
| Operating CF Growth % | 18.38% | 54.83% | 81.5% | -76.08% | 77.99% | 3.95% | -5.55% | 0.86% | 101.78% | -13.97% | 118.71% | 281.32% | 220.54% | 8.98% | 6.49% | 35.91% | -389% | 95.04% | -407.71% | 89.79% | -24.4% | -3.04% | 69.92% | 62.49% | -23.91% | -253.1% | -424.49% | - |
| Net Income | -2.53M | 13.49M | 15.89M | 13.49M | 25.93M | 5.2M | 23.83M | 6.2M | 8.25M | 32.04M | -4.36M | 23.6M | 14.33M | -1.42M | -1.07M | -707K | 34.89M | -3.65M | -8.02M | -2.43M | -17.97M | -21.77M | -21.18M | -96.11M | -942.89M | -3.07B | -118.7M | -6.3M |
| Depreciation & Amortization | 143K | 1.81M | 2.91M | 2.83M | 4.06M | 12.09M | 4.95M | 487K | -1.93M | -3.11M | 10K | 3K | 2K | 5K | 2K | 0 | 1.69M | 1.77M | 1.3M | 1.59M | 2.46M | 6.82M | 15.41M | 30.55M | 153.61M | 896.75M | 82M | 1.5M |
| Stock-Based Compensation | 1.18M | 944K | 509K | 500K | 1.16M | 728K | 530K | 267K | 300K | 363K | 640K | 844K | 254K | 586K | 81K | 8K | 1.63M | 2.21M | 2.87M | 3.43M | 38K | 1.35M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 4.81M | -1.29M | -3.94M | 6.95M | -1.71M | -7.1M | 31K | 15.74M | -21.64M | 3.27M | -10.3M | -9.8M | 0 | -169K | 0 | 0 | 0 | -2.86M | -2.14M | 499K | -1.35M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 21.48M | 1.46M | -2.17M | -1.2M | -4.29M | 1.75M | -1.52M | 14.3M | -3.44M | 2.94M | 12.45M | -8.98M | -3.36M | -24K | -56K | -777K | -43.29M | 1.23M | 3.45M | 4.91M | 5.6M | 3.84M | -965K | 44.4M | 633.9M | 2.09B | 1.6M | -100K |
| Working Capital Changes | 7.03M | 534K | -966K | -3.47M | 479K | 1.21M | -2.15M | -1.65M | 533K | -959K | -798K | -39K | -78K | -261K | -17K | 166K | 3.04M | -1.98M | -5.17M | -7.02M | -6.89M | -1.97M | -5.95M | -21.02M | 42.94M | -8.11M | 9.4M | 0 |
| Change in Receivables | 1.93M | -1.06M | -1.64M | -1.29M | 108K | 643K | -214K | -558K | -583K | -457K | -74K | -525K | -331K | -197K | 0 | 0 | 2.42M | 1.7M | -479K | -2.35M | -1.52M | 4.08M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | -787K | 0 | -108K | -643K | 214K | 0 | 0 | 0 | 0 | 0 | -981K | 1.03M | 0 | 0 | 0 | 0 | 0 | 0 | -2.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.59M | -1.33M | 396K | -1.6M | 2.16M | 1.53M | -1.73M | -1.3M | 1.16M | -106K | -76K | 498K | 234K | -94K | -14K | 201K | 0 | 0 | -2.22M | -4.04M | 129K | 1.75M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 68.06M | -10.13M | -48.95M | -43.55M | 25.76M | -35.17M | -26.72M | -28.13M | -12.12M | -21.05M | -18.88M | -55.63M | -20.07M | -19.5M | 169K | 1.94M | 36.36M | -1.06M | -2.79M | -860K | 4.99M | 9.42M | 1.97M | 2.44M | 49.56M | 22.39M | -44.4M | -900K |
| Capital Expenditures | 0 | -138K | -496K | -297K | -1.08M | -3.94M | -48K | 0 | 0 | 0 | -50K | -1K | -4K | -4K | 0 | -6K | -351K | -1.17M | -1.95M | -860K | -465K | -895K | -1.23M | -12.25M | -16.78M | -35.64M | -8.4M | -900K |
| CapEx % of Revenue | 1.26% | 0.31% | 1.31% | 0.72% | 1.92% | 10.72% | 0.16% | - | - | - | 0.21% | 0.01% | 0.06% | 0.63% | - | - | 0.78% | 1.79% | 3.21% | 1.59% | 1.08% | 1.83% | 2.02% | 15.49% | 18.52% | 31.53% | 59.57% | 39.13% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Investments | 184K | 580K | 48K | 76K | 4.64M | 4.94M | 2.27M | 532K | 1.86M | 9.61M | 13.27M | 13.89M | 13.54M | 13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.36M | 7.32M | 10.54M | 14.65M | 297K | 34.52M | 200K |
| Other Investing | 68.06M | -10.6M | -62.39M | -47.45M | 24.84M | -31.34M | -7.06M | -28.42M | -12.56M | -22.5M | -18.91M | -53.9M | -17.06M | -6.5M | 169K | 1.95M | 36.71M | 20K | 74K | 0 | -932K | 352K | -13K | 10.57M | 25.76M | 23.81M | 0 | -100K |
| Cash from Financing | -58.51M | -12.22M | 33.14M | -1.36M | -20.2M | 7.75M | -883K | -1.83M | -8.96M | -3.7M | -3.77M | 101.57M | 1.8M | 7M | 0 | 22K | -2.64M | 4.62M | 9.94M | 2.01M | 4.41M | 824K | 14.18M | 36.05M | 12.99M | 126.16M | 75M | 12.3M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | -3.07M | -6.01M | -6.33M | -1.14M | -368K | -2.01M | -883K | -1.36M | 0 | 0 | -196K | 110.15M | 0 | 0 | 0 | 22K | 0 | 0 | 10.39M | 2.94M | 6.33M | 824K | 14.22M | 33.46M | 11.48M | 128.37M | 66.9M | 18.2M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -3.07M | -6.01M | -6.33M | -1.14M | -368K | -2.01M | -883K | -1.36M | 0 | 0 | -213K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -49.21M | -93K | -3.41M | -2.66M | -8.08M | -2M | 0 | -469K | -8.96M | -3.7M | -3.58M | -3.58M | -2.86M | 7M | 0 | 0 | 0 | 0 | 0 | 5.9M | -5.9M | 0 | 0 | 594K | 2.09M | 945K | 500K | -7.6M |
| Net Change in Cash | 36.84M | 691K | -920K | -36.71M | 39.85M | -8.15M | -9.07M | -10.33M | -1.63M | -15.11M | -11.44M | 51.06M | -16.92M | -13.62M | -1.06M | 651K | 31.62M | 2.68M | -1.41M | -497K | -7.56M | -2.51M | 3.67M | -3.51M | -50.73M | 57.51M | 4.8M | 6.5M |
| Free Cash Flow | 26.77M | 22.91M | 14.39M | 7.91M | 33.22M | 15.33M | 18.49M | 19.63M | 19.46M | 9.64M | 11.16M | 5.12M | 1.34M | -1.12M | -1.23M | -1.32M | -2.4M | -1.59M | -10.38M | -2.52M | -16.73M | -13.97M | -13.92M | -54.43M | -129.22M | -126.38M | -34.1M | -5.8M |
| FCF Margin % | 65.69% | 50.93% | 38.11% | 19.06% | 59.15% | 41.76% | 60.13% | - | 51.91% | 43.09% | 47.57% | 29.45% | 20.78% | -175.67% | - | - | -5.29% | -2.43% | -17.08% | -4.67% | -38.79% | -28.56% | -22.81% | -68.82% | -142.64% | -111.83% | -241.84% | -252.17% |
| FCF Growth % | 16.86% | 59.19% | 82.06% | -76.2% | 116.67% | -17.08% | -5.8% | 0.86% | 101.78% | -13.59% | 117.78% | 282.39% | 219.75% | 8.65% | 6.91% | 45.05% | -50.91% | 84.72% | -311.9% | 84.93% | -19.76% | -0.37% | 74.43% | 57.88% | -2.24% | -270.63% | -487.93% | - |
| FCF per Share | 2.20 | 1.84 | 1.13 | 0.61 | 2.59 | 1.19 | 1.43 | 1.50 | 1.49 | 0.74 | 0.86 | 0.79 | 0.32 | -0.27 | -0.30 | -0.32 | -0.58 | -0.39 | -2.80 | -0.73 | -5.43 | -4.82 | -5.79 | -24.30 | -94.03 | -162.84 | -222.09 | -92.68 |
| FCF Conversion (FCF/Net Income) | -10.77x | 1.71x | 0.94x | 0.61x | 1.32x | 3.70x | 0.78x | 3.17x | 6.39x | 0.33x | -1.52x | 0.25x | 0.10x | 0.78x | 1.15x | 1.85x | -0.06x | 0.11x | 1.05x | 0.68x | 0.91x | 0.60x | 0.61x | 0.44x | 0.12x | 0.03x | 0.22x | 0.39x |
| Interest Paid | 0 | 3.08M | 1.35M | 268K | 110K | 137K | 0 | 0 | 0 | 0 | 0 | 446K | 21K | 0 | 0 | 0 | 978K | 236K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 0 | 0 | 0 | 0 | 96K | 118K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Portfolio Valuation Volatility
As reported in recent financial statements, SWKH exhibits a volatile relationship between net income and operating cash flow, highlighted by a 2025Q4 period where the company generated $10.3 million in operating cash despite reporting a significant net loss of $19.4 million, suggesting substantial non-cash accounting adjustments.
The wide variance between net income and operating cash flow suggests that headline earnings are heavily influenced by non-cash valuation adjustments on the royalty portfolio. Investors should monitor this divergence, as it indicates that reported profitability may not accurately reflect the underlying cash-generating capacity of the finance receivables segment.
Based on the provided cash flow data, SWKH's free cash flow trajectory remains inconsistent, with quarterly margins fluctuating from a low of 5.1% in 2025Q3 to a peak of 128.9% in 2025Q4, reflecting the lumpy nature of royalty receipts and project-based licensing income within the business.
The erratic FCF margins suggest that the company's cash generation is highly sensitive to the timing of specific royalty payments and milestone events. This lack of predictability complicates the assessment of long-term cash flow sustainability and may necessitate a multi-year average approach to valuation.
According to historical cash flow filings, SWKH experiences significant quarterly swings in working capital, such as the $5.1 million outflow in 2025Q3 followed by a $3.8 million inflow in 2025Q4, which underscores the operational complexity of managing a diverse portfolio of life science finance receivables.
These working capital fluctuations appear to be driven by the timing of interest collections and the settlement of royalty contracts. The volatility in these accounts suggests that short-term liquidity may be subject to timing mismatches that do not necessarily reflect a deterioration in the quality of the underlying assets.
As evidenced by the company's financial statements, SWKH has prioritized share repurchases and a significant $49.1 million dividend payment in 2025Q2, while maintaining a low debt profile, which suggests management is currently focused on returning capital rather than aggressive reinvestment into new royalty or lending opportunities.
The decision to return substantial capital to shareholders, coupled with a lack of significant new acquisitions, may indicate a scarcity of attractive investment opportunities in the current biotech environment. This strategy preserves the balance sheet but raises questions regarding the company's long-term growth prospects and capital deployment velocity.
Quick answers to the most common questions about buying SWKH stock.
SWK Holdings Corporation (SWKH) generated $27.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
SWK Holdings Corporation (SWKH) generated $26.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
SWK Holdings Corporation (SWKH) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, SWK Holdings Corporation (SWKH) spent $3.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.